Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand

por Deerochanawong, Chaicharn, Krittayaphong, Rungroj, Romano, Jack Garcia Uranga, Rhee, Nicolai A., Permsuwan, Unchalee
Publicado 2023

Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand

por Deerochanawong, Chaicharn, Krittayaphong, Rungroj, Romano, Jack Garcia Uranga, Rhee, Nicolai A., Permsuwan, Unchalee
Publicado 2023

Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market

por Murthy, Sreenivasa, Aneja, Pankaj, Asirvatham, Arthur Joseph, Husemoen, Lise Lotte N., Rhee, Nicolai A., Kesavadev, Jothydev
Publicado 2021

CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries

por Mosenzon, Ofri, Alguwaihes, Abdullah, Leon, Jose Luis Arenas, Bayram, Fahri, Darmon, Patrice, Davis, Timothy M. E., Dieuzeide, Guillermo, Eriksen, Kirsten T., Hong, Tianpei, Kaltoft, Margit S., Lengyel, Csaba, Rhee, Nicolai A., Russo, Giuseppina T., Shirabe, Shinichiro, Urbancova, Katerina, Vencio, Sergio
Publicado 2021